Protective effect of rosiglitazone against hyperoxia-induced lung injury in neonatal rats

Chinese Journal of Contemporary Pediatrics

Volumn 14, Issue 4, 2012, Pages 301-305

  Cai, Qun ^a   Xu, Mei Yu ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Hyperoxic lung injury; Malondialdehyde; Neonatal rats; Peroxisome proliferator activated receptor ; Rosiglitazone

Indexed keywords

MALONALDEHYDE; ROSIGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL SWELLING; CONTROLLED STUDY; HISTOLOGY; HYPEROXIA; LEUKOCYTE COUNT; LUNG ALVEOLUS; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; LUNG INJURY; LUNG LAVAGE; NEWBORN; NEWBORN DISEASE; NONHUMAN; RAT;

ANIMALS; ANIMALS, NEWBORN; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HYPEROXIA; LUNG INJURY; MALE; MALONDIALDEHYDE; PPAR GAMMA; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLIDINEDIONES;

EID: 84863666771     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Merritt TA, Deming DD, Boynton BR. The 'new' bronchopulmonary dysplasia: challenges and commentary[J]. Semin Fetal Neonatal Med, 2009, 14 (6): 345-357.
2. Belvisi MG, Hele DJ. Peroxisome proliferator-activated receptors as novel targets in lung disease[J]. Chest, 2008, 134 (1): 152-157. (Pubitemid 352008777)
3. Cuzzocrea S, Pisano B, Dugo L, Lanaro A, Patel NS, Di Paola R, et al. Rosiglitazone a ligand of the peroxisome proliferator-activated receptor -gamma, reduces the development of nonseptic shock induced by zymosan in mice[J]. Crit Care Med, 2004, 32 (2): 457-466. (Pubitemid 38234126)
4. Oh SH, Park SM, Lee YH, Cha JY, Lee JY, Shin EK, et al. Association of peroxisome proliferator-activated receptor-gamma gene polymorphisms with the development of asthma[J]. Respir Med, 2009, 103 (7): 1020-1024.
5. Dasqupta C, Sakurai R, Wang Y, Guo P, Ambalavanan N, Tordayjs, et al. Hyperoxia-induced neonatal rat lung injury involves activation of TGF-β and Wnt signaling and is protected by rosiglitazone[J]. Am J Physiol Lung Cell Mol Physiol, 2009, 296 (6): 1031-1041.
6. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tunder RM, Voelkel NF, et al. Inhibition of angiogenesis decreases alveolarizationin in the developing rat lung[J]. Am J Physiol Lung Cell Mol Physiol, 2000, 279 (3): L600-L607.
7. Blanco LN, Frank L. The formation of alveoli in rat lung during the third and fourth postnatal weeks: effect of hyperoxia, dexamethasone, and deferoxamine[J]. Pediatr Res, 1993, 34 (3): 334-340. (Pubitemid 23254554)
8. Birrell MA, Patel HJ, McCluskie K, Wong S, Leonard T, Yacoub MH, et al. PPAR-gamma agonists as therapy for diseases involving airway neutrophilia[J]. Eur Respir J, 2004, 24 (1): 18-23. (Pubitemid 39029065)
9. Collino M, Aragno M, Masrocola R, Gallicchio M, Rosa AC, Dianzani C, et al. Modulation of the oxidative stress and inflammatory response by PPAR-γ agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion[J] . Eur Pharmacol, 2006, 530 (1-2): 70-80. (Pubitemid 43037126)
10. Trombetta A, Maggiora M, Martinasso G, Cotogni P, Canuto RA, Muzio G. Arachidonic and docosahex aenoic acids reduce the growth of A549 human lung tumor cells increasing lipid peroxidation and PPARs[J]. Chem Biol Interact, 2007, 165 (3): 239-250. (Pubitemid 46237619)